Suchergebnisse - "Sun, Jun-Hui"

PubPharm (86)

1

Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma : A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial)

enthalten in: Cardiovascular and interventional radiology | 2024

von Zhu, H. | Li, X. | Sun, J. | +13

2

Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial)

enthalten in: CardioVascular and interventional radiology | 2024

von Zhu, H. | Li, X. | Sun, J. | +13

3

Arterial chemotherapy for hepatocellular carcinoma in China : consensus recommendations

enthalten in: Hepatology international | 2024

von Zhao, M. | Guo, Z. | Zou, Y. | +36

4

Development and experimental validation of a machine learning-based disulfidptosis-related ferroptosis score for hepatocellular carcinoma

enthalten in: Apoptosis : an international journal on programmed cell death | 2024

von Zhang, C. | Xu, T. | Ji, K. | +7

5

Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211) : a propensity score matching study

enthalten in: European radiology | 2023

von Jin, Z. | Zhong, B. | Chen, J. | +14

6

Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization

enthalten in: Journal of clinical and translational hepatology | 2023

von Zhong, B. | Jiang, J. | Sun, J. | +6

7

An integrative analysis reveals the prognostic value and potential functions of PSMD11 in hepatocellular carcinoma

enthalten in: Molecular carcinogenesis | 2023

von Zhang, C. | Xu, T. | Ji, K. | +5

8

Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis : a multicenter randomized trial

enthalten in: International journal of surgery (London, England) | 2023

von Lu, J. | Guo, J. | Ji, J. | +24

9

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

enthalten in: Signal transduction and targeted therapy | 2023

von Zhu, H. | Li, H. | Huang, M. | +62

10

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7

enthalten in: Journal of hepatocellular carcinoma | 2023

von Jiang, J. | Huang, J. | Zhong, B. | +6

1
2
3
4
5
6
7
8
9
Nächster »
[9]